At present, the researchers do not recommend altering patient preparation or stopping GLP-1 agonists prior to FDG PET-CT scans. Instead, they advise that imaging teams carefully document patients' ...

Researchers from University Hospital Cologne have reported in a proof-of-concept study that two PET/CT radiotracers – F-18 FDG and Ga-68 FAPI-46 – work better together than when used alone for cancer ...

A new approach to PET imaging offers a promising way for physicians to promptly identify patients who are at risk for poor ...

Niagara Falls, NY, May 29, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging systems and services, is pleased to announce the sale ...

Please provide your email address to receive an email when new articles are posted on . A 70-year-old woman had a PET/CT scan to evaluate her prior history of endometrial adenocarcinoma. No evidence ...

A new approach to PET imaging offers a promising way for physicians to promptly identify patients who are at risk for poor ...

LOS ANGELES -- Screening with 18 F-fluorocholine PET/CT imaging had the best detection capability for identifying parathyroid adenoma, according to a new study. Among 30 patients with primary ...

Popular weight-loss drugs Ozempic and others can affect medical scans. New research shows these medications interfere with ...

IRVINE, Calif.--(BUSINESS WIRE)--Alliance HealthCare Radiology (“Alliance Radiology”), a subsidiary of Alliance HealthCare Services, announced today the acquisition of four PET/CT locations owned by ...

A study by K. Lance Gould, M.D., professor in the Division of Cardiology at the UT Medical School at Houston -- published today on the cover page of the Journal of Nuclear Medicine -- says PET-CT ...

» How do PET/CT radiation doses compare with doses from other examinations? » Can repeated radiological procedures on the same patient increase the radiation risk? » Does diabetes have any additional ...

Surgical resection is the standard local therapy for stage I and II NSCLC; however, significant comorbidities may preclude surgical resection in those who are able to tolerate the procedure. For these ...